Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

ACURA PHARMACEUTIC COM USD0.01 (ACUR)

0.6201 0 (0.02%)

02-23 11:03

Open:

0.6216

Pre. Close:

0.62

High:

0.6216

Low:

0.6201

Volume:

926

Market Cap:

13M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.62 - 0.624

0.624 - 0.628

Low:

0.611 - 0.615

0.615 - 0.62

Close:

0.613 - 0.62

0.62 - 0.626

Technical analysis  (as of: 2018-02-23 4:39:52 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 0.85     One year: 0.98

Support:

Support1: 0.55    Support2: 0.46

Resistance:

Resistance1: 0.73    Resistance2: 0.84

Pivot:

0.63

Moving Averages:

MA(5): 0.66     MA(20): 0.63

MA(100): 0.48     MA(250): 0.50

MACD:

MACD(12,26): 0.02     Signal(12,26,9): 0.03

%K %D:

%K(14,3): 19.96     %D(3): 35.15

RSI:

RSI(14): 50.74

52-Week:

High: 0.87  Low: 0.29  Change(%): 24.0

Average Vol(K):

3-Month: 2848  10-Days 847

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ACUR has closed above bottom band by 42.3%. Bollinger Bands are 20.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 13 Feb 2011 05:27:45 GMT
News Acura Pharmaceuticals Inc.ACUR

Tue, 07 Feb 2017 21:11:15 GMT
Acura Pharmaceuticals Seeks To Raise $5 Million In Offering

Fri, 17 Mar 2017 10:07:30 GMT
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed ...

Wed, 15 Feb 2017 21:11:15 GMT
Acura Pharmaceuticals Common Stock To Trade On The OTCQB Market

Mon, 09 Oct 2017 10:07:30 GMT
Acura Pharmaceuticals Advances LTX-03 and its LIMITx™ Technology

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

Shares Float (M)

% Held by Insiders

% Held by Institutions

Shares Short (K)

Shares Short Prior Month (K)

85

Stock Financials

EPS

EPS Est. Current Year

-0.460

EPS Est. Next Year

0.370

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

PEG Ratio

Profit Margin

Operating Margin

-26.17

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

-61.9

Gross Profit (p.s.)

0.193

Sales Per Share

EBITDA (p.s.)

-0.069

Qtrly Earnings Growth

Operating Cash Flow (M)

-1.11

Levered Free Cash Flow (M)

-0.21

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

P/S

26322612.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2015-08-28

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.